These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 389155)
1. [beta-Lactamase inhibition as 1 of the ways of overcoming resistance to beta-lactam antibiotics]. Prokopenko VM; Tereshin IM Antibiotiki; 1979 Nov; 24(11):867-73. PubMed ID: 389155 [No Abstract] [Full Text] [Related]
2. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics. Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768 [TBL] [Abstract][Full Text] [Related]
3. An explicit model for bacterial resistance: application to beta-lactam antibiotics. Waley SG Microbiol Sci; 1987 May; 4(5):143-6. PubMed ID: 3153188 [TBL] [Abstract][Full Text] [Related]
5. Beta-lactamases as the main resistance factor to penicillin-related antibiotics. Frère JM; Joris B Ann Biol Clin (Paris); 1988; 46(2):151-6. PubMed ID: 3260085 [TBL] [Abstract][Full Text] [Related]
6. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. Weston GS; Blázquez J; Baquero F; Shoichet BK J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697 [TBL] [Abstract][Full Text] [Related]
8. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies. Dudley M Pharmacotherapy; 1995; 15(1 Pt 2):9S-14S. PubMed ID: 7753692 [TBL] [Abstract][Full Text] [Related]
9. Inhibitors of metallo-beta-lactamase generated from beta-lactam antibiotics. Badarau A; Llinás A; Laws AP; Damblon C; Page MI Biochemistry; 2005 Jun; 44(24):8578-89. PubMed ID: 15952764 [TBL] [Abstract][Full Text] [Related]
10. [Penicillins and beta-lactamase inhibitors]. Gac Med Mex; 1992; 128(2):127-30. PubMed ID: 1302208 [No Abstract] [Full Text] [Related]
11. [Characteristics of the substrate specificity of the crude endogenous beta-lactamases of gram-negative bacteria]. Bibikova MV; Ivanitskaia LP; Nikishina VG; Kuznetsova SM Antibiotiki; 1983 Aug; 28(8):566-73. PubMed ID: 6416154 [TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of resistance to beta-lactam inhibitors of beta-lactamases]. Blázquez J Rev Esp Quimioter; 1998 Dec; 11(4):368-9. PubMed ID: 10336318 [No Abstract] [Full Text] [Related]
13. The evolution of antibiotic production and public health problems. Mansford KR; Slocombe B Chemioterapia; 1987 Jun; 6(3):234-40. PubMed ID: 3496977 [TBL] [Abstract][Full Text] [Related]
14. Evolution of beta-lactamase inhibitors. Jackson D Pharmacotherapy; 1991; 11(2 ( Pt 2)):37S-39S. PubMed ID: 2041830 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases. Kotra LP; Mobashery S Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868 [TBL] [Abstract][Full Text] [Related]
16. [Indicator method of determining the beta-lactamase-inhibiting activity of various compounds]. Ivanitskaia LP; Nikishina VG Antibiotiki; 1981 Apr; 26(4):259-64. PubMed ID: 6972191 [TBL] [Abstract][Full Text] [Related]